Article Details

Palisade Bio (NASDAQ:PALI) Upgraded to “Hold” at Zacks Investment Research - KOP Source

Retrieved on: 2022-05-01 12:09:00

Tags for this article:

Click the tags to see associated articles and topics

Palisade Bio (NASDAQ:PALI) Upgraded to “Hold” at Zacks Investment Research - KOP Source. View article details on HISWAI: https://www.kopsource.com/2022/05/01/palisade-bio-nasdaqpali-upgraded-to-hold-at-zacks-investment-research.html

Excerpt

According to Zacks, “Palisade Bio Inc. is a late-stage biopharma company advancing therapies which help patients with acute and chronic ...

Article found on: www.kopsource.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up